
During the COVID pandemic in March 2020, SSRL resumed operations, under a minimum operations mode, to support critical COVID-19 related research. This session will highlight some recent results that employed X-ray light source facilities to further our understanding COVID-19 and aid in the search for an effective vaccine or other treatments.
Organizers:
Aina Cohen, SLAC National Accelerator Laboratory/SSRL
Clyde Smith, SLAC National Accelerator Laboratory/SSRL
Agenda
8:00am Introduction: Support of COVID-19 research at SSRL
Aina Cohen, SLAC National Accelerator Laboratory/SSRL
8:15am Keynote Lecture
Structural evaluation of the neutralizing antibody response to SARS CoV-2
Ian Wilson (The Scripps Research Institute)
9:00am Keynote Lecture
Structural insights into the feline coronavirus drug GC376, which inhibits the main protease of SARS-CoV-2 and blocks virus replication
M. Joanne Lemieux (University of Alberta)
9:45am Structures of human antibodies bound to the SARS-CoV-2 spike glycoprotein define correlates of antibody-mediated neutralization
Christopher Barnes (California Institute of Technology)
10:15am Break – 15 minutes
10:30am Covid-19 Quarantine Related Changes in Particulate Matter Source and Speciation
Benjamin Bostick (Columbia University)
11:00am Molecular biomimicry of the SARS-CoV-2 virus and consequences for severe inflammation
Gerard Wong (University of California, Los Angeles)
11:30am Finding ligands for the Nsp3 Macrodomain of SARS-CoV-2?
James Fraser (University of California, San Francisco)
12:00pm Follow up discussion
12:30pm Adjourn